Ludovic Juen

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Acute Myeloid Leukemia

Tyrosine Kinase

Diffusion Weighted

Top Venues

Bioconjugate chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Ludovic Juen, Christine B Baltus, Camille Gély, Thibault Kervarrec, Ofelia Feuillâtre, Audrey Desgranges, Marie-Claude Viaud-Massuard, Camille Martin
Therapeutic Potential of MF-TTZ-MMAE, a Site-Specifically Conjugated Antibody-Drug Conjugate, for the Treatment of HER2-Overexpressing Breast Cancer. Bioconjugate chemistry 33 (2) (2022)
Ludovic Juen, Christine B Baltus, Camille Gély, Ofelia Feuillâtre, Audrey Desgranges, Marie-Claude Viaud-Massuard, Camille Martin
Innovative Bioconjugation Technology for Antibody-Drug Conjugates: Proof of Concept in a CD30-Positive Lymphoma Mouse Model. Bioconjugate chemistry 32 (3) (2021)
Marie Brachet-Botineau, Margaux Deynoux, Nicolas Vallet, Marion Polomski, Ludovic Juen, Olivier Herault, Fréderic Mazurier, Marie-Claude Viaud-Massuard, Gildas Prié, Fabrice Gouilleux
A Novel Inhibitor of STAT5 Signaling Overcomes Chemotherapy Resistance in Myeloid Leukemia Cells. Cancers 11 (12) (2019)